News Dupixent Approved for Eczema in Young Children June 7, 2022 Read More » Lantus No Longer Restricted to Type 1 Diabetes in Pediatric Patients June 7, 2022 Read More » Riabni Gains Indication to Treat Rheumatoid Arthritis June 6, 2022 Read More » FDA Approves Priorix to Prevent Measles, Mumps, and Rubella June 6, 2022 Read More » Cancer Drug Ukoniq Withdrawn from Market Over Safety Concerns June 1, 2022 Read More » FDA Approves Beovu to Treat Diabetic Macular Edema June 1, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in June May 31, 2022 Read More » Evrysdi Now Indicated to Treat SMA in Patients of Any Age May 31, 2022 Read More » Kymriah Granted New Indication for Follicular Lymphoma May 28, 2022 Read More » Page1 … Page29 Page30 Page31 Page32 Page33 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in June May 31, 2022 Read More »